Iseult acts for clients in the technology and life sciences sectors on corporate and commercial matters. Iseult has over a decade of experience advising on company formation and equity structures, venture capital and venture debt transactions, bridge financings, exits and pre-exit secondary sales, share options and incentive plans, joint ventures, commercial transactions and corporate governance.
Iseult has particular expertise in international venture capital financings of Irish structures using the US NVCA framework.
Clients include technology, life sciences and other venture-backed companies, as well as venture capital funds investing in Irish entities.
Iseult is a leading member of the Corporate Technology Transactions practice within the firm’s Technology and Innovation Group.